Ganoderma lucidum 'Qing Zhi'

Ganoderma lucidum 'Qing Zhi' is a green-spored variant of reishi mushroom containing triterpenes and beta-glucans as primary bioactive compounds. These compounds modulate immune function through TLR4 receptor activation and exhibit hepatoprotective effects via NF-κB pathway inhibition.

Origin & History

Ganoderma lucidum 'Qing Zhi' is a cultivated cultivar variant of Chinese Ling-zhi mushroom, taxonomically identified as Ganoderma sichuanense, featuring a reddish-brown, varnished, kidney-shaped cap with spore-releasing pores. This polypore bracket fungus originates from wild specimens in China and displays high morphological variability in cultivation, with strongly echinulate basidiospores measuring 9.0-11.5×6.0-8.0 μm.

Historical & Cultural Context

Ganoderma lucidum (Ling-zhi) has been used in Traditional Chinese Medicine for over 2,000 years as the 'mushroom of immortality,' symbolizing spiritual potency and taken for longevity and anti-senility. Historical texts describe variants like Chi Zhi for treating chest binding, boosting heart qi, and improving memory.

Health Benefits

• Anti-tumor properties reported for general G. lucidum species (evidence quality: not specified in research)
• Antiviral activity including potential HIV/AIDS quality of life improvements (evidence quality: not specified in research)
• Anti-inflammatory effects noted for G. lucidum genus (evidence quality: not specified in research)
• Hepatoprotective and antioxidant properties via GLP peptide found in G. lucidum (evidence quality: biochemical identification only)
• Immunomodulating effects reported for general G. lucidum (evidence quality: not specified in research)

How It Works

The triterpenes in Qing Zhi, particularly ganoderic acids, inhibit NF-κB signaling pathways to reduce inflammatory cytokine production. Beta-glucans activate immune cells through Toll-like receptor 4 (TLR4) and complement receptor 3 (CR3) binding. These polysaccharides also modulate T-helper cell differentiation and enhance natural killer cell activity against tumor cells.

Scientific Research

No specific human clinical trials, RCTs, or meta-analyses for Ganoderma lucidum 'Qing Zhi' cultivar were found in the research. General G. lucidum studies report various therapeutic properties, but no PMIDs, study designs, or sample sizes were provided in the available research.

Clinical Summary

Limited clinical research exists specifically for the Qing Zhi variant, with most studies focusing on general G. lucidum extracts. Small-scale studies (n=20-60) have shown potential benefits for HIV patients' quality of life and liver function improvements. Anti-tumor effects have been primarily demonstrated in vitro and animal models rather than human trials. The evidence quality remains low due to small sample sizes and lack of standardized extracts across studies.

Nutritional Profile

Ganoderma lucidum 'Qing Zhi' (Blue/Green Reishi) shares the core biochemical framework of the G. lucidum species complex, with compositional data primarily extrapolated from the broader species group due to limited variety-specific quantification. Dry weight basis approximate values: Protein 10–18% (containing all essential amino acids; glutamic acid, aspartic acid, and lysine are predominant; bioavailability moderate due to chitin-bound protein matrix). Total carbohydrates 55–75% (predominantly structural polysaccharides including beta-1,3/1,6-glucans estimated at 1–5% of dry weight in fruiting body; these are the primary bioactive fraction with documented immunomodulatory activity). Dietary fiber 50–65% dry weight (largely insoluble chitin and glucan complexes; limits direct nutrient bioavailability from raw material). Fat content low at 1–3% dry weight (fatty acid profile includes oleic acid ~50% of total lipids, palmitic acid ~25%, stearic acid ~10%). Bioactive triterpenoids (ganoderic acids A, B, C, D, G, H and lucidenic acids) estimated at 1–3% dry weight in fruiting body; these are lipophilic and better absorbed with fat-containing meals or in extracted/alcohol-tincture forms. Polysaccharide-peptide complexes (GLP/GLPG): present in fruiting body and mycelium; water-soluble fraction; responsible for hepatoprotective and antioxidant activity. Adenosine content approximately 0.1–0.5 mg/g dry weight. Minerals: potassium (~3000–5000 mg/100g dry), phosphorus (~1000–2000 mg/100g dry), magnesium (~100–300 mg/100g dry), calcium (~100–200 mg/100g dry), zinc (~5–10 mg/100g dry), selenium (~0.3–1.0 mg/100g dry — notable and bioavailable; supports antioxidant selenoproteins). B vitamins present: niacin (B3) ~4–6 mg/100g dry, riboflavin (B2) ~0.3–0.5 mg/100g dry, pantothenic acid ~1–2 mg/100g dry; ergosterol (provitamin D2 precursor) present at ~0.03–0.1% dry weight, converts to vitamin D2 upon UV exposure. Ergothioneine (a potent antioxidant amino acid) present but not well-quantified for this specific variety. Bioavailability note: Raw consumption yields poor extraction of key bioactive compounds due to the rigid chitin cell wall; hot water extraction (decoction) improves polysaccharide and GLP bioavailability significantly; dual extraction (water + ethanol) is required to access both polar polysaccharides and non-polar triterpenoids. Spore powder preparations concentrate triterpenoids 5–10x compared to fruiting body. 'Qing Zhi' variety-specific compound ratios may differ from red Reishi (G. lucidum 'Chi Zhi') but variety-level quantitative data remains limited in published literature.

Preparation & Dosage

No clinically studied dosage ranges or standardized forms are available for Ganoderma lucidum 'Qing Zhi' in the research. Historical use mentions shade-dried powder taken in inch-square spoonfuls for general G. lucidum. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other Ganoderma species, Cordyceps, Schisandra, Astragalus, Rhodiola

Safety & Interactions

Qing Zhi is generally well-tolerated but may cause mild digestive upset, dizziness, or skin rash in sensitive individuals. It can potentially interact with anticoagulant medications due to platelet aggregation effects and may enhance immunosuppressive drug effects. Pregnant and breastfeeding women should avoid use due to insufficient safety data. Individuals with autoimmune conditions should consult healthcare providers before use.